| Schedule of Basic and Diluted Net Loss Per Share |
Basic and diluted net loss per share attributable to common stockholders and Series A Preferred stockholders was calculated as follows (in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, 2026 |
|
|
Six Months Ended
June 30, 2026 |
|
|
|
Loss Allocation |
|
|
Weighted Average
Shares Outstanding |
|
|
Loss Per Share -
Basic and Diluted |
|
|
Loss Allocation |
|
|
Weighted Average
Shares Outstanding |
|
|
Loss Per Share -
Basic and Diluted |
|
Common Stock |
|
$ |
(46,211 |
) |
|
|
61,050,775 |
|
|
$ |
(0.76 |
) |
|
$ |
(79,291 |
) |
|
|
59,423,013 |
|
|
$ |
(1.33 |
) |
Series A Preferred Stock (1) |
|
|
(9,554 |
) |
|
|
12,622 |
|
|
$ |
(756.93 |
) |
|
|
(16,842 |
) |
|
|
12,622 |
|
|
$ |
(1,334.34 |
) |
Net loss |
|
$ |
(55,765 |
) |
|
|
|
|
|
|
|
$ |
(96,133 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, 2025 |
|
|
Six Months Ended June 30, 2025 |
|
|
|
Loss Allocation |
|
|
Weighted Average
Shares Outstanding |
|
|
Loss Per Share -
Basic and Diluted |
|
|
Loss Allocation |
|
|
Weighted Average
Shares Outstanding |
|
|
Loss Per Share -
Basic and Diluted |
|
Common Stock |
|
$ |
(24,552 |
) |
|
|
28,431,158 |
|
|
$ |
(0.86 |
) |
|
$ |
(54,985 |
) |
|
|
15,932,206 |
|
|
$ |
(3.45 |
) |
Series A Preferred Stock (2) |
|
|
(7,582 |
) |
|
|
8,781 |
|
|
$ |
(863.46 |
) |
|
|
(15,318 |
) |
|
|
4,439 |
|
|
$ |
(3,450.78 |
) |
Net loss |
|
$ |
(32,134 |
) |
|
|
|
|
|
|
|
$ |
(70,303 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) The weighted average number of shares of as-converted Series A Preferred Stock used in the loss allocation was 12,622,000 for both the three and six months ended June 30, 2026. (2) The weighted average number of shares of as-converted Series A Preferred Stock used in the loss allocation was 8,780,522 and 4,438,505 for the three and six months ended June 30, 2025, respectively.
|
| Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share |
The potentially dilutive securities are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three and Six Months Ended June 30, 2026 |
|
|
Three and Six Months Ended June 30, 2025 |
|
Outstanding and unvested RSAs |
|
|
274,811 |
|
|
|
495,739 |
|
Outstanding and issued common stock options |
|
|
13,162,759 |
|
|
|
9,348,097 |
|
Outstanding and unvested Restricted stock units |
|
|
489,854 |
|
|
|
— |
|
Outstanding and issued warrant to Parade |
|
|
804,519 |
|
|
|
— |
|
Total |
|
|
14,731,943 |
|
|
|
9,843,836 |
|
|